Puerto Rico Consulting was Pharma-Bio Serv’s largest region in fiscal 2025, bringing in $4.64M of $9.00M (52%).
| Geography | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Puerto Rico Consulting | $12.14M | $8.04M | $5.69M | $4.64M | |||||||||||
| United States Consulting | $4.56M | $4.67M | $3.16M | $2.62M | |||||||||||
| Ireland Consulting | — | — | — | — | |||||||||||
| Europe Consulting | $2.65M | $4.26M | $571.18K | $1.73M | |||||||||||
| Lab (Microbiological & Chemical Testing) | — | — | — | — | |||||||||||
| Other Segments | — | — | — | — | |||||||||||
| Brazil Consulting | — | — | — | — | |||||||||||
| Other | $47.65K | $6.23K | $85.78K | $16.67K | |||||||||||
| Total | $19.40M | $16.98M | $9.51M | $9.00M |
Pharma-Bio Serv brought in $9.00M from its four regions in fiscal 2025, the year ended October 31, 2025. That was down 5.3% from $9.51M in fiscal 2024. Puerto Rico Consulting was the largest at $4.64M (51.5%), ahead of United States Consulting at $2.62M (29.1%) and Europe Consulting at $1.73M (19.2%). The remaining region, Other, brought in $16.67K.
Compared with fiscal 2024, Europe Consulting grew fastest, up 202.4% to $1.73M, while Puerto Rico Consulting fell the most, down 18.5% to $4.64M. From fiscal 2022 to 2025, combined revenue from these regions fell from $19.40M to $9.00M, a compound annual decline of 22.6%. Puerto Rico Consulting's share of the total fell from 62.6% to 51.5%.
Pharma-Bio Serv (PBSV) reports its revenue by geography. In fiscal 2025, Puerto Rico Consulting was its largest region, bringing in $4.64M (51.5% of the total), followed by United States Consulting at $2.62M (29.1%).
Puerto Rico Consulting was Pharma-Bio Serv's largest region in fiscal 2025, bringing in $4.64M, or 51.5% of the $9.00M total across its four regions.
Among Pharma-Bio Serv's regions that make up at least 2% of revenue, Europe Consulting grew fastest in fiscal 2025, up 202.4% from $571.18K to $1.73M.
Every figure comes from Pharma-Bio Serv's annual financial filings, as reported. Each line keeps the name Pharma-Bio Serv gives it, and years follow its fiscal calendar.
Pharma-Bio Serv's revenue by geography goes back to fiscal 2011, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.